In Vitro Fertilization (IVF) Market Size, Emerging Trends, Forecasts, and Analysis 2022-2028

As per the study, the market is expected to grow from USD 669.9 million in 2021 to USD 1,256.35 million by 2028 at a CAGR of over 9.29% during the forecast period of 2022-2028.

Stratview Research has published a new report titled “In Vitro Fertilization (IVF) Market” which is segmented by Reagent (Embryo Culture Media, Cryopreservation Media, Sperm Processing Media, OVUM Processing Media), by Equipment (Imaging Systems, Sperm Separation Systems, Cabinets, OVUM Aspiration Pumps, Incubators, Micromanipulator Systems, Gas Analyzers and Other), by Cycle (Fresh Non-Donor IVF Cycles, Frozen Non-Donor IVF Cycles, Frozen Donor IVF Cycles, Fresh Donor IVF Cycles), by End User (Fertility Clinics Surgical Centers, Hospitals Research Laboratories, Cryobanks) and by Region (North America, Asia-Pacific, Europe, and the Rest of World).

 

As per the study, the market is expected to grow from USD 669.9 million in 2021 to USD 1,256.35 million by 2028 at a CAGR of over 9.29% during the forecast period of 2022-2028.

In Vitro Fertilization is defined as a type of assisted reproduction in which a women’s eggs and man’s sperm are combined outside of the body in a Petri/laboratory dish. IVF is the most widely used method for assisted reproduction due to the usage of advanced technology and favorable reimbursement policies.

 

Report Highlights

This report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can affect the industry’s market dynamics. It provides a thorough analysis of the market segments which include products, applications, and competitor analysis.

 

The market is bifurcated into various segments. Below given is the segment-wise analysis -

By End User

The Fertility Clinics Surgical Centers segment accounted for the largest market share of more than 76.0% in 2021.

The market has been segmented into fertility clinics surgical centers, hospitals research laboratories, and cryobanks. The segment growth can be attributed to the increasing number of fertility clinic centers coupled with rising infertility rates globally.

 

By Reagent 

The Embryo Culture Media segment accounted for the largest market share of more than 40.0% in 2021.

The market has been segmented into Embryo Culture Media, Cryopreservation Media, Sperm Processing Media, and OVUM Processing Media). The expansion was ascribed to factors such as increased research efforts to improve media for culture, and more accessible funding.

 

By Cycle

The Frozen Non-Donor IVF Cycles segment accounted for the largest market share of more than 45.0% in 2021.

The market has been segmented into Fresh Non-Donor IVF Cycles, Frozen Non-Donor IVF Cycles, Frozen Donor IVF Cycles, and Fresh Donor IVF Cycles. The segment is expected to register the fastest growth over the forecast period. The high percentage can be attributed to the cost-effectiveness when compared to fresh non-donor sperm, as well as the procedure's less-invasive nature.

 

Which Region is expected to remain the largest market?

The market in Europe accounted for the largest market share of more than 35.0% in 2021 owing to increasing infertility rates; rising awareness, and continuous spending on RD activities to develop technologically advanced solutions for health problems.

The market in Asia-Pacific is expected to register the fastest growth during the review period on account of the growing median age of first-time motherhood, rising infertility rates, and low treatment costs.

 

Who are the Key Players in the market?

This report provides market intelligence most comprehensively. It also provides critical insights into the key players active in the market, which will enable strategic decision-making for the existing market players as well as those willing to enter the market. The following are the key players acting in the In Vitro Fertilization (IVF) Market:

  • Cooper Surgical Inc. (The U.S.)
  • Vitro Life (Sweden)
  • Cook Medical Incorporated (The U.S.)
  • Thermo Fisher Scientific (The U.S.)
  • Irvine Scientific (The U.S.)
  • Genea Limited (Australia)
  • The Baker Company, Inc. (The U.S.)
  • Kitazato Corporation (Japan)
  • Esco Micro Pte Ltd (Singapore)
  • EMD Serono (The U.S.)
  • IVF Tech APS (Denmark)
  • Rocket Medical (UK)

 

Key questions answered by the report.

  • What is the projected CAGR for revenue from the In Vitro Fertilization (IVF) Market during the forecast period?
  • What would the market be valued at by 2028?
  • What is a major driving factor for the growth of the market?
  • Which region accounted for the largest revenue share in the In Vitro Fertilization (IVF) Market?
  • Which are the major market players?

 

Custom Research:

Stratview Research delivers custom research services across sectors. In case of any custom research requirements, please send your inquiry to sales@stratviewresearch.com. Or connect with our experts at +1-313-307-4176.

 

About Us

Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with insightful market data to aid strategic decision-making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.


Gourav Guwal

5 Blog posts

Comments